Themis Medicare Q2 FY27 consolidated revenue Rs 89.74 cr, PAT Rs 7.06 cr
Themis Medicare’s consolidated Q2 FY27 net revenue was Rs 89.74 cr and PAT Rs 7.06 cr, versus Rs 77.99 cr and a loss of Rs (3.62) cr in Q2 FY26.
Key takeaways
- Net revenue Rs 89.74 cr in Q2 FY27 vs Rs 77.99 cr in Q2 FY26.
- Total expenditure Rs 84.17 cr in Q2 FY27 vs Rs 81.08 cr in Q2 FY26.
- EBITDA Rs 5.58 cr in Q2 FY27 vs Rs (3.09) cr in Q2 FY26.
- PAT Rs 7.06 cr in Q2 FY27 vs Rs (3.62) cr in Q2 FY26.
- Basic EPS Rs 0.77 in Q2 FY27 vs Rs (0.39) in Q2 FY26.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 89.74 cr | Rs 77.99 cr | +15.1% |
| PAT | Rs 7.06 cr | Rs (3.62) cr | +295.0% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
-
Net margin was 7.87% of revenue, against -4.64% a year earlier.
-
Revenue rose 15.1% while total expenses rose 3.8%.
-
Basis & period: Consolidated quarterly financial highlights – Q2 FY27, quarter ended 30th September 2026, compared with Q2 FY26, from the consolidated quarterly financial highlights table in the investor presentation.
-
Net revenue: Rs 89.74 cr in Q2 FY27, up from Rs 77.99 cr in Q2 FY26 ("Net Revenue" line in the consolidated quarterly financial highlights – Q2 FY27 table).
-
Total expenditure: Rs 84.17 cr in Q2 FY27, up from Rs 81.08 cr in Q2 FY26 ("Total Expenditure").
-
EBITDA: Rs 5.58 cr in Q2 FY27 versus Rs (3.09) cr in Q2 FY26 ("EBITDA").
-
EBITDA margin: 6.22% in Q2 FY27 versus (3.96%) in Q2 FY26 ("EBITDA Margin").
-
Other income: Rs 4.14 cr in Q2 FY27 versus Rs 3.24 cr in Q2 FY26 ("Other Income").
-
Depreciation: Rs 2.56 cr in Q2 FY27 versus Rs 2.57 cr in Q2 FY26 ("Depreciation").
-
Interest / finance cost: Rs 2.11 cr in Q2 FY27 versus Rs 2.76 cr in Q2 FY26 ("Interest / Finance Cost").
-
PBT: Rs 8.22 cr in Q2 FY27 versus Rs (3.45) cr in Q2 FY26 ("PBT").
-
Tax: Rs 1.16 cr in Q2 FY27 versus Rs 0.16 cr in Q2 FY26 ("Tax").
-
PAT: Rs 7.06 cr in Q2 FY27 versus Rs (3.62) cr in Q2 FY26 ("PAT").
-
PAT margin: 7.86% in Q2 FY27 versus (4.64%) in Q2 FY26 ("PAT Margin%").
-
Basic EPS: Rs 0.77 in Q2 FY27 versus Rs (0.39) in Q2 FY26 ("Basic EPS in Rs.").
According to the consolidated quarterly financial highlights – Q2 FY27 table in the investor presentation, Themis Medicare’s consolidated net revenue for the quarter ended 30th September 2026 was Rs 89.74 cr, compared with Rs 77.99 cr in the corresponding quarter of the previous year. Total expenditure rose to Rs 84.17 cr from Rs 81.08 cr over the same period.
EBITDA moved to Rs 5.58 cr in Q2 FY27 from Rs (3.09) cr in Q2 FY26, with the EBITDA margin at 6.22% versus (3.96%) a year earlier, as per the same table. Other income increased to Rs 4.14 cr from Rs 3.24 cr, while depreciation was broadly similar at Rs 2.56 cr versus Rs 2.57 cr. Interest / finance cost declined to Rs 2.11 cr from Rs 2.76 cr.
The table shows profit before tax at Rs 8.22 cr in Q2 FY27 compared with a loss of Rs (3.45) cr in Q2 FY26. Tax expense was Rs 1.16 cr versus Rs 0.16 cr in the year-ago quarter. Profit after tax turned to Rs 7.06 cr from a loss of Rs (3.62) cr, with the PAT margin at 7.86% compared with (4.64%) in Q2 FY26. Basic EPS for the quarter was Rs 0.77, against Rs (0.39) in the corresponding prior period.
Track Themis Medicare Ltd
Cruxal reads every Themis Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.